Update: 22.02.2021
Last week: 6 week 2022 (7.01.2022 - 13.02.2022)
Last full month: Jan 2021
| Time period | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | |||||||||
| WoW | 2 700 | -0.5% | 52.1% | -1.3 | 1 206 747 | 0.1% | 80.4% | -0.7 | 2.0% |
| MoM | 9 905 | 26.3% | 51.5% | 5.7 | 4 344 704 | 26.7% | 79.8% | 4 | 12.3% |
| YTD | 14 643 | 0.8% | 52.3% | -6.1 | 6 462 516 | 27.8% | 80.4% | -0.5 | 12.6% |
| MAT | 117 727 | -23.0% | 55.0% | -6.8 | 47 017 098 | 1.7% | 80.3% | -1 | -13.5% |
| CAPSICAM | |||||||||
| WoW | 23 029 | -3.0% | 3.4% | -0.2 | 9 375 589 | -3.3% | 3.5% | -0.2 | 2.8% |
| MoM | 98 524 | -7.4% | 3.6% | -0.5 | 40 398 608 | -6.6% | 3.8% | -0.5 | 5.6% |
| YTD | 135 874 | -10.3% | 3.5% | -0.2 | 55 615 363 | -12.9% | 3.7% | -0.6 | -5.1% |
| MAT | 1 049 542 | -20.3% | 3.1% | -0.3 | 430 710 498 | -11.0% | 3.4% | -0.3 | -12.7% |
| MILDRONATE | |||||||||
| WoW | 123 179 | 4.6% | 22.2% | 0.1 | 56 555 583 | 8.4% | 21.0% | 0.8 | 4.2% |
| MoM | 430 377 | 3.2% | 21.8% | -0.7 | 175 100 313 | 7.9% | 19.0% | 0 | 6.5% |
| YTD | 633 363 | 12.0% | 16.8% | 0.8 | 268 159 925 | 10.0% | 15.5% | 0.1 | 6.7% |
| MAT | 4 863 768 | 9.6% | 17.3% | 2.8 | 1 957 942 098 | 12.3% | 15.4% | 2.1 | -8.2% |
| SULFARGIN | |||||||||
| WoW | 3 416 | 3.3% | 0.9% | 0 | 1 636 227 | 2.8% | 1.3% | 0 | 3.3% |
| MoM | 13 779 | -21.2% | 0.9% | -0.3 | 6 745 395 | -20.1% | 1.3% | -0.3 | 4.0% |
| YTD | 19 103 | 0.1% | 0.9% | 0.1 | 9 296 456 | 5.0% | 1.3% | 0.2 | -10.6% |
| MAT | 164 178 | -21.6% | 0.8% | -0.1 | 80 198 674 | -9.5% | 1.2% | 0 | -12.2% |
| VIPROSAL | |||||||||
| WoW | 31 707 | -0.3% | 4.6% | -0.1 | 12 446 931 | -0.7% | 4.7% | -0.1 | 1.8% |
| MoM | 121 819 | -11.4% | 4.4% | -0.8 | 48 011 965 | -11.8% | 4.6% | -0.9 | 4.8% |
| YTD | 173 536 | 32.1% | 4.5% | 1.3 | 68 281 848 | 33.9% | 4.6% | 1.1 | -6.4% |
| MAT | 1 285 672 | -8.2% | 3.8% | 0.2 | 488 564 396 | -0.3% | 3.9% | 0.1 | -12.9% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 2 700 | -0.5% | 52.1% | -1.3 | 1 206 747 | 0.1% | 80.4% | -0.7 | 2.0% |
| CAPSICAM | 23 029 | -3.0% | 3.4% | -0.2 | 9 375 589 | -3.3% | 3.5% | -0.2 | 2.8% |
| MILDRONATE | 123 179 | 4.6% | 22.2% | 0.1 | 56 555 583 | 8.4% | 21.0% | 0.8 | 4.2% |
| SULFARGIN | 3 416 | 3.3% | 0.9% | 0 | 1 636 227 | 2.8% | 1.3% | 0 | 3.3% |
| VIPROSAL | 31 707 | -0.3% | 4.6% | -0.1 | 12 446 931 | -0.7% | 4.7% | -0.1 | 1.8% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 9 905 | 26.3% | 51.5% | 5.7 | 4 344 704 | 26.7% | 79.8% | 4 | 12.3% |
| CAPSICAM | 98 524 | -7.4% | 3.6% | -0.5 | 40 398 608 | -6.6% | 3.8% | -0.5 | 5.6% |
| MILDRONATE | 430 377 | 3.2% | 21.8% | -0.7 | 175 100 313 | 7.9% | 19.0% | 0 | 6.5% |
| SULFARGIN | 13 779 | -21.2% | 0.9% | -0.3 | 6 745 395 | -20.1% | 1.3% | -0.3 | 4.0% |
| VIPROSAL | 121 819 | -11.4% | 4.4% | -0.8 | 48 011 965 | -11.8% | 4.6% | -0.9 | 4.8% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 14 643 | 0.8% | 52.3% | -6.1 | 6 462 516 | 27.8% | 80.4% | -0.5 | 12.6% |
| CAPSICAM | 135 874 | -10.3% | 3.5% | -0.2 | 55 615 363 | -12.9% | 3.7% | -0.6 | -5.1% |
| MILDRONATE | 633 363 | 12.0% | 16.8% | 0.8 | 268 159 925 | 10.0% | 15.5% | 0.1 | 6.7% |
| SULFARGIN | 19 103 | 0.1% | 0.9% | 0.1 | 9 296 456 | 5.0% | 1.3% | 0.2 | -10.6% |
| VIPROSAL | 173 536 | 32.1% | 4.5% | 1.3 | 68 281 848 | 33.9% | 4.6% | 1.1 | -6.4% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 117 727 | -23.0% | 55.0% | -6.8 | 47 017 098 | 1.7% | 80.3% | -1 | -13.5% |
| CAPSICAM | 1 049 542 | -20.3% | 3.1% | -0.3 | 430 710 498 | -11.0% | 3.4% | -0.3 | -12.7% |
| MILDRONATE | 4 863 768 | 9.6% | 17.3% | 2.8 | 1 957 942 098 | 12.3% | 15.4% | 2.1 | -8.2% |
| SULFARGIN | 164 178 | -21.6% | 0.8% | -0.1 | 80 198 674 | -9.5% | 1.2% | 0 | -12.2% |
| VIPROSAL | 1 285 672 | -8.2% | 3.8% | 0.2 | 488 564 396 | -0.3% | 3.9% | 0.1 | -12.9% |
Abbreviations
WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1
MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1
YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date
MAT - Moving Annual Total - a period, being any 12 month period ending on the last week
MS - Market Share
Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs